  Background Achieving hepatitis C elimination is hampered by the costs of
treatment and the need to treat hard-to-reach populations. Treatment access
could be widened by shortening treatment, but limited research means it is
unclear which strategies could achieve sufficiently high cure rates to be
acceptable. We present the statistical aspects of a multi-arm trial designed to
test multiple strategies simultaneously with a monitoring mechanism to detect
and stop those with unacceptably low cure rates quickly. Methods The VIETNARMS
trial will factorially randomise patients to three randomisations. We will use
Bayesian monitoring at interim analyses to detect and stop recruitment into
unsuccessful strategies, defined as a >0.95 posterior probability of the true
cure rate being <90%. Here, we tested the operating characteristics of the
stopping guideline, planned the timing of the interim analyses and explored
power at the final analysis. Results A beta(4.5, 0.5) prior for the true cure
rate produces <0.05 probability of incorrectly stopping a group with true cure
rate >90%. Groups with very low cure rates (<60%) are very likely (>0.9
probability) to stop after ~25% patients are recruited. Groups with moderately
low cure rates (80%) are likely to stop (0.7 probability) before the end of
recruitment. Interim analyses 7, 10, 13 and 18 months after recruitment
commences provide good probabilities of stopping inferior groups. For an
overall true cure rate of 95%, power is >90% to detect non-inferiority in the
regimen and strategy comparisons using 5% and 10% margins respectively,
regardless of the control cure rate, and to detect a 5% absolute difference in
the ribavirin comparison. Conclusions The operating characteristics of the
stopping guideline are appropriate and interim analyses can be timed to detect
failing groups at various stages.
